[HTML][HTML] The ameliorative effects of saikosaponin in thioacetamide-induced liver injury and non-alcoholic fatty liver disease in mice

GR Chang, WL Lin, TC Lin, HJ Liao, YW Lu - International journal of …, 2021 - mdpi.com
Liver disorders are a major health concern. Saikosaponin-d (SSd) is an effective active
ingredient extracted from Bupleurum falcatum, a traditional Chinese medicinal plant, with …

[HTML][HTML] Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study

X Li, X Li, J Lu, Y Huang, L Lv, Y Luan, R Liu… - BMC complementary and …, 2017 - Springer
Abstract Background Radix Bupleuri (RB) has been popularly used for treating many liver
diseases such as chronic hepatic inflammation and viral Hepatitis in China. Increasing …

Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling

A Liu, N Tanaka, L Sun, B Guo, JH Kim… - Chemico-biological …, 2014 - Elsevier
Overdose of acetaminophen (APAP) can cause acute liver injury that is sometimes fatal,
requiring efficient pharmacological intervention. The traditional Chinese herb Bupleurum …

[HTML][HTML] Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease

X Li, J Ge, Y Li, Y Cai, Q Zheng, N Huang, Y Gu… - … Pharmaceutica Sinica B, 2021 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) has become one of the most prominent causes of
chronic liver diseases and malignancies. However, few therapy has been approved. Radix …

[HTML][HTML] Saikosaponin‑d alleviates carbon‑tetrachloride induced acute hepatocellular injury by inhibiting oxidative stress and NLRP3 inflammasome activation in the …

L Lin, R Que, Y Shen, Y Chen… - Molecular medicine …, 2018 - spandidos-publications.com
Saikosaponin‑d (SSd) the primary active component of triterpene saponin derived from
Bupleurum falcatum L., possesses anti‑inflammatory and antioxidant properties. The present …

Saikosaponins ameliorate hyperlipidemia in rats by enhancing hepatic lipid and cholesterol metabolism

Q Zheng, X Li, N Huang, F Li, J Ge, D Wang… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Hyperlipidemia is the systemic manifestation of abnormal
lipid metabolism, characterized by elevated circulating levels of cholesterol and triglyceride …

Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα

Y Zhu, X Chen, X Rao, C Zheng, X Peng - International …, 2019 - Elsevier
Saikosaponin a (SSa), one of the major active components of Bupleurum falcatum, has
antioxidant and anti-inflammatory pharmacological properties. However, the effects of SSa …

Inhibition of oxidative stress and NLRP3 inflammasome by Saikosaponin-d alleviates acute liver injury in carbon tetrachloride-induced hepatitis in mice

Y Chen, R Que, L Lin, Y Shen… - International Journal of …, 2020 - journals.sagepub.com
NLRP3 inflammasome activation results in severe liver inflammation and injury.
Saikosaponin-d (SSd) possesses anti-inflammatory and hepatoprotective effects. This study …

Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury

J Fan, X Li, P Li, N Li, T Wang, H Shen… - … and cell biology, 2007 - cdnsciencepub.com
Treatment of liver fibrosis and cirrhosis remains a challenging field. Hepatocyte injury and
the activation of hepatic stellate cells are the 2 major events in the development of liver …

Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway

Y Gu, S Duan, M Ding, Q Zheng, G Fan, X Li, Y Li, C Liu… - Phytomedicine, 2022 - Elsevier
Background Metabolic associated fatty liver disease (MAFLD) is a progressive chronic liver
disease, yet there is still a lack of effective pharmacological therapies at present …